Cyclopharm Limited Investor Relations Material
Latest events
Investor Update
Cyclopharm Limited
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Cyclopharm Limited
Access all reports
Cyclopharm Limited is an Australia-based health technology company primarily engaged in the manufacture and sale of medical equipment and radiopharmaceuticals. The company operates through two main segments: Technegas and Molecular Imaging. The Technegas segment focuses on providing diagnostic equipment and consumables used by physicians in the detection of pulmonary embolism. It also distributes products to the diagnostic imaging sector. The Molecular Imaging segment is involved in producing radiopharmaceuticals for the detection of cancer, neurological disorders, and cardiac disease. The company is headquartered in Kingsgrove, New South Wales, and its shares are listed on the ASX.
Key slides for Cyclopharm Limited
Investor Update
Cyclopharm Limited
Investor Update
Cyclopharm Limited
Latest articles
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
Ticker symbol
CYC
Country
🇦🇺 Australia